Conakry

AFP by Rod Mac Johnson                                              April 7, 2015

FREETOWN -- Police in Ebola-hit Sierra Leone raided a funeral and arrested 13 people suspected of organising an unsafe burial, risking spreading the disease, officers said on Tuesday.

Police superintendent Da Samah said "heavily-armed" police arrived just in time to stop a 50-year-old man being interred on the outskirts of Freetown after they were tipped off about the ceremony....

He said those present at the funeral on Thursday last week were arrested because they had no burial permit or other required documents...

Palo Conteh, the national Ebola response chief, said traditional funeral rights involving contact with the dead remained the biggest driver of Ebola transmission.
 Read complete story.

http://news.yahoo.com/ebola-hit-sierra-leone-arrests-13-unsafe-burial-132356956.html

news-medical.net - April 6, 2015

Adam C. Levine, M.D., an emergency medicine physician at Rhode Island Hospital and The Miriam Hospital who treated Ebola-infected patients in Liberia last year, used his field experience to create a tool to determine the likelihood that patients presenting with Ebola symptoms will actually carry the virus. His research was published in the Annals of Emergency Medicine today.

(READ COMPLETE ARTICLE)

CLICK HERE - RESEARCH - Derivation and Internal Validation of the Ebola Prediction Score for Risk Stratification of Patients With Suspected Ebola Virus Disease

REUTERS by Sharon Bagley                                                                      April 1, 2015

Early-stage trials of an experimental Ebola vaccine, two in the United States and four in Africa and Europe, have found that it appears to be safe and triggered robust production of Ebola-fighting antibodies, scientists reported on Wednesday.

Since trials cannot ethically expose volunteers to Ebola, the production of antibodies is a proxy for whether vaccines could prevent or even treat the disease.

The trials all tested a vaccine called VSV-ZEBOV, which was developed at the Public Health Agency of Canada and licensed to NewLink Genetics Corp and then to Merck & Co Inc. It consists of a cattle virus called rVSV that has been engineered to carry Ebola genes, which produce proteins meant to trigger production of anti-Ebola antibodies.

According to separate teams of scientists, that is what happened, two papers in the New England Journal of Medicine reported.

Read complete story.
http://www.reuters.com/article/2015/04/01/us-health-ebola-vaccine-idUSKBN0MS5DN20150401

Read NEW ENGLAND JOURNAL OF MEDICINE  papers

WHO                                                                                                          March 31, 2015
Cristiana Salvi, a risk communications specialist from WHO’s European regional office was deployed to Guinea at the end of April – early May 2014 to provide social mobilization support to the Ebola response. Social mobilization involves working with communities to gain their acceptance of the need for early identification of people with illness, early treatment and identification and follow up of all people who have been in contact with people confirmed to have Ebola virus disease.

 Cristiana was among the first from WHO offices other than Headquarters and the African office to provide support to the field response, many others followed from the “wider WHO”. She travelled to Gueckedou where communities had begun to hide people who were sick, fearing treatment centres, believing rumours Ebola response teams were there for sinister purposes. This is what she found.

Excerpt: